MediXall Group, Inc.
MDXL
$0.0001
-$0.0038-97.44%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -26.33% | -55.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -26.33% | -55.29% | |||
| Cost of Revenue | -8.54% | -18.05% | |||
| Gross Profit | 1.10% | -25.02% | |||
| SG&A Expenses | -30.92% | 23.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.60% | 2.03% | |||
| Operating Income | 20.92% | -24.14% | |||
| Income Before Tax | 154.29% | 0.14% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 154.29% | 0.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 154.29% | 0.14% | |||
| EBIT | 20.92% | -24.14% | |||
| EBITDA | 20.92% | -24.30% | |||
| EPS Basic | 134.15% | 2.38% | |||
| Normalized Basic EPS | 40.91% | 4.35% | |||
| EPS Diluted | 134.15% | 2.38% | |||
| Normalized Diluted EPS | 40.91% | 4.35% | |||
| Average Basic Shares Outstanding | 16.88% | 3.57% | |||
| Average Diluted Shares Outstanding | 16.88% | 3.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||